A tiny, wireless pacemaker could offer some heart patients a surgery-free alternative to the traditional devices, a new study says. Some doctors, however, say there are lingering safety questions and warned patients not to rush to get the new technology.
Amgen Inc. has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades.
How many kids are vaccinated at your child's school? Federal health officials think you should be able to easily find out.
Even though Linda Ellerbee has addressed many tough topics with young audiences before, it took a decade before Nickelodeon approved her idea of a "Nick News" episode where children with terminal illnesses talk about their lives.
The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men.
Barely 2 years old, Talia Pisano is getting tough treatment for kidney cancer that spread to her brain. She's also getting a chance at having babies of her own someday.
The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades.
New research suggests it may be possible to predict which preschoolers will struggle to read - and it has to do with how the brain deciphers speech when it's noisy.
The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors.
For pregnant women, abnormal results from certain prenatal tests may signal that something is wrong — with the moms-to-be, not the fetus, a preliminary study suggests.
The pushback against soaring cancer drug prices is gaining steam. A leading doctors group on Monday proposed a formula to help patients decide if a medicine is worth it — what it will cost them and how much good it is likely to do.
Federal health regulators said Monday a highly-anticipated, experimental drug from Amgen significantly lowers bad cholesterol. But officials have questions about who should take the drug and whether to approve it based on currently available data.
Women suffering from low libido got some hope this week when a panel of health experts said the government should approve an experimental pill intended to boost sexual desire. It is the first time a government panel has endorsed such a drug. The move surprised many experts, because the Food and Drug Administration has twice rejected the drug due to lackluster effectiveness and worrisome side effects.
The drug industry's decade-spanning search for a female equivalent to Viagra took a major step forward Thursday, as government experts recommended approval for a pill to boost sexual desire in women.
Are you sitting down? In that case, you should probably stand up before reading this.